When it comes to discussing medication risks, a new study shows, rheumatologists and their patients are speaking different languages. The article reveals how doctors may be sending messages they don't intend.
Prior authorizations have begun to spread pandemic-like from high-cost biologics to treatments used routinely in rheumatology. The time burden on rheumatologists is insupportable, contends the author, who says it's time to take action.
Antinuclear antibody testing and DEXA both appear on a new Canadian list of rheumatology tests to avoid and on a similar 2013 list from the American College of Rheumatology. There are interesting differences in the other 3 choices.
Oral etidronate, IV pamidronate, and then zoledronate caused bone markers to normalize in this 80-year-old woman—temporarily. What’s going on? Answer this and questions on 3 other topics in this week’s quiz.